Epigral's Q1 FY27 revenue grew 16% to ₹705.36 crore. However, standalone profit after tax fell 38% to ₹99.18 crore due to the absence of a prior year one-time deferred tax credit. The company also incorporated a new subsidiary and is developing a hybrid power project.
Detailed Coverage
H1 Epigral Q1 FY27 Financials Show Revenue Growth, Profit Decline
Standalone Revenue (Jun-26): ₹705.36 crore
Standalone PAT (Jun-26): ₹99.18 crore
Reader Takeaway: Revenue up but profit down due to one-time tax credit removal.
What just happened
Epigral Limited reported a 16.29% year-on-year increase in standalone revenue for the quarter ending June 30, 2026, reaching ₹705.36 crore from ₹606.54 crore in the same period last year. However, standalone Profit After Tax (PAT) saw a significant decline of 38.17%, dropping to ₹99.18 crore from ₹160.41 crore in the corresponding quarter of the previous year.
Why this matters
The reported drop in profit is attributed to the absence of a ₹80.87 crore one-time deferred tax credit that was recognized in the prior year's comparable quarter. This means the core operational performance, reflected in revenue growth, remains positive, but the net profit figure is affected by this base effect. The company's strategic initiatives in new subsidiary incorporation and captive power development are key factors for future growth.
The backstory
In the previous year, Epigral's PAT was boosted by a one-time deferred tax credit. This quarter's results are being compared against that inflated figure, leading to the sharp percentage decrease in PAT. The company's revenue has shown consistent growth, indicating underlying business expansion.
What changes now
Investors will look beyond the headline PAT figure to the revenue growth and the strategic progress. The incorporation of Epigral Advanced Material Limited and the development of the wind-solar hybrid power plant are crucial steps for enhancing manufacturing capabilities and reducing operational costs.
Risks to watch
The primary risk is the impact of market conditions on future revenue growth and profitability. The success of the new subsidiary and the operational efficiency of the captive power project will be critical for long-term performance.
Peer comparison
(No peer comparison data available in the filing.)
Context metrics (time-bound)
Standalone Revenue (Jun-26): ₹705.36 crore vs. ₹606.54 crore (Jun-25), a 16.29% increase.
Standalone PAT (Jun-26): ₹99.18 crore vs. ₹160.41 crore (Jun-25), a 38.17% decrease.
What to track next
Investors should monitor the performance of the new subsidiary, Epigral Advanced Material Limited, and the progress of the 19.80 MW captive power project. The company's ability to maintain revenue momentum and manage costs will be key indicators.